Subscribe
shutterstock_106097018_vepar5
vepar5 / Shutterstock.com
16 May 2019Generics

EU adopts SPC manufacturing waiver

The European Union has adopted the proposed supplementary protection certificate (SPC) manufacturing waiver, despite criticism from parts of the pharmaceutical industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
Generics
EC plans to lower barriers to generic drugs
25 November 2020   The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
Generics
EC plans to lower barriers to generic drugs
25 November 2020   The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

More on this story

Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.
Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
Generics
EC plans to lower barriers to generic drugs
25 November 2020   The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York